NCT06397144View on ClinicalTrials.gov

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

June 10, 2025

Study Completion Date

June 10, 2025

Conditions
Biological AvailabilityHealthy Participants
Interventions
DRUG

Paxlovid

Reference 1

DRUG

Paxlovid

Reference 2

DRUG

Nirmatrelvir/ritonavir

Test 1

DRUG

Nirmatrelvir/ritonavir

Test 2

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06397144 - A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants | Biotech Hunter | Biotech Hunter